Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News NY Valves 2024 National Data Point to Soaring TAVI Rates in Patients Under 65 Michael O'Riordan June 14, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News EuroPCR 2024 TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis Michael O'Riordan May 16, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement Presenter: Eliano Navarese May 15, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Daily News STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios Yael L. Maxwell May 01, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024